MedCost Clear Cost calculator

What changes for GLP-1 costs on January 1, 2027

Only changes an official source has published: CMS and Medicare.gov, the makers' self-pay listings on TrumpRx.gov, and FDA. Grouped by how you pay. Checked Nov 14, 2026.

Short answer

On January 1, 2027, Medicare's negotiated price for semaglutide (Ozempic, Rybelsus, Wegovy) takes effect at $274 for a 30-day supply, and the Part D yearly out-of-pocket limit rises to $2,400. For self-pay, Novo Nordisk's $199 new-patient price and Foundayo's temporary low-dose prices end on December 31, 2026. Medicare's $50 GLP-1 Bridge continues through 2027.1514168

Source: CMS, Medicare.gov, TrumpRx.gov · checked Nov 14, 2026

Get your dates as a calendar file

If you have Medicare

If you pay yourself (self-pay)

If you take Saxenda

If you have commercial insurance or Medicaid

Not on this page: changes reported only in the news (for example new list prices or savings-card end dates) until the official wording is published and we can cite it.

Which drug, which dose, and whether to start, stop or switch are medical decisions. Ask your doctor or pharmacist.

Official sources for this page (17)
  1. “Ozempic; Rybelsus; Wegovy Novo Nordisk Inc. Type 2 diabetes; Type 2 diabetes and cardiovascular disease; Cardiovascular disease and obesity/ overweight $274 $959 71%”
  2. “These negotiated prices will become effective on January 1, 2027.”
  3. “A participating drug company with a selected drug is required to ensure the negotiated price is made available to eligible individuals and to the pharmacies, mail-order services, and other entities that dispense the selected drug with respect to such individuals.”
  4. “00169-4130-13 4 mg/3 mL Pen, 1 Pen (Ozempic) $276.78 00169-4307-30 7 mg, 30 Tablets (Rybelsus) $276.78 00169-4524-14 2.4 mg /0.75 mL Pen, 4 Pens (Wegovy) $385.63”
  5. “Out-of-Pocket Threshold: $2,100 Out-of-Pocket Threshold: $2,400”
  6. “Deductible: $615 Deductible: $700”
  7. “Out-of-pocket limit Yearly $2,100 (in 2026).”
    Medicare.gov: Medicare costs · as of Oct 23, 2026
  8. “The Centers for Medicare & Medicaid Services (CMS) is extending the Medicare GLP-1 Bridge through December 31, 2027.”
    CMS HPMS memo, April 21, 2026 · as of Oct 17, 2026
  9. “Your prior authorization is valid (including for refills and dose changes) through December 31, 2027, unless you change GLP-1s.”
    Medicare.gov: Weight loss drugs · as of Nov 5, 2026
  10. “Doesn’t count towards your yearly Medicare drug plan deductible or out-of-pocket limit and won’t appear on your Part D Explanation of Benefits (EOB).”
    Medicare.gov: Weight loss drugs · as of Nov 5, 2026
  11. “Starting July 1, 2026, Medicare covers these GLP-1 drugs: Foundayo® (tablet) Wegovy® (injection or tablet) Zepbound® (KwikPen® only. The program doesn’t cover single-dose Zepbound® vials or pens).”
    Medicare.gov: Weight loss drugs · as of Nov 5, 2026
  12. “CMS will delay implementation of the Medicare Part D portion of Better Approaches to Lifestyle and Nutrition for Comprehensive Health (BALANCE) Model for Calendar Year (CY) 2027 pending further evaluation and data collection.”
    CMS HPMS memo, April 21, 2026 · as of Oct 17, 2026
  13. “Open Enrollment Period October 15-December 7 … January 1 of the next year (the plan must get your request to join by December 7)”
  14. “Limited Time Offer – New patients pay $199* for the first two monthly fills of Wegovy® (semaglutide) injection 0.25mg and 0.5mg, then $349/month. Only available for 2 monthly fills between 11/17/2025- 12/31/2026. For each fill after, pay $349/month for Wegovy® 0.25mg, 0.5mg, 1mg, 1.7mg, or 2.4mg and $399/month for Wegovy® HD 7.2mg.”
  15. “Limited Time Offer – New self-pay patients pay $199* for the first two monthly fills of Ozempic® (semaglutide) injection 0.25mg or 0.5mg. Only available for 2 monthly fills between 11/17/2025 – 12/31/2026. For each fill after, pay $349/month for Ozempic® 0.25mg, 0.5mg or 1mg, and $499/month for Ozempic® 2mg. For eligible patients only.”
  16. “The price for the 2.5mg dose is temporarily reduced through December 31, 2026. Regular price is $199. The price for the 5.5mg dose is temporarily reduced through December 31, 2026. Regular price is $299. *Eligibility required, terms and conditions apply. Review full terms and conditions.”
  17. “Product will be available until discontinuation in January 2027”

Did this page answer your question?